发现SOCS7作为一种用于蛋白质基降解剂的多功能E3结合酶
Anaïs Cornebois1,2, Marie Sorbara1, Margot Cristol1
1Université de Toulouse, Inserm, CNRS, Université Toulouse III-Paul Sabatier, Centre de Recherches en Cancérologie de Toulouse, 31100 Toulouse, France.
iScience
|May 15, 2024
概括
研究人员确定SOCS7 E3酶是向蛋白质降解 (TPD) 的新工具. 这种多功能生物降解剂有效地消耗蛋白,通过抑制胰腺癌细胞中的突变KRAS来提供抗癌的新策略.
科学领域:
- 分子生物学分子生物学
- 生物化学 生物化学
- 在瘤学瘤学.
背景情况:
- 向蛋白降解 (TPD) 使用无素-蛋白酶体系统 (UPS) 来消除感兴趣的蛋白质 (POI).
- 在E3结合酶的可用性和抵抗机制的局限性阻碍了当前的TPD策略.
- 发现新型E3链酶对于推进TPD和克服耐药性至关重要.
研究的目的:
- 为了识别针对蛋白质降解的新型E3链酶.
- 开发新的降解剂,并规避对现有 TPD 方法的抗性.
- 评估已识别的E3链酶在降解标蛋白和抑制癌细胞增殖方面的有效性.
主要方法:
- 采用基于蛋白质的降解方法,将抗标签细胞内抗体与E3结合酶融合.
- 选了能够降解被标记的感兴趣蛋白质 (POI) 的E3连接酶.
- 在胰腺癌细胞中生成并测试了一种基于SOCS7的降解剂,针对突变KRAS.
主要成果:
- 鉴定了SOCS7 E3酶作为针对蛋白质降解的有效生物降解剂.
- SOCS7在消耗各种细胞系和亚细胞局部的点蛋白质方面表现出有效性.
- 一种基于SOCS7的KRAS降解剂成功抑制了突变的KRAS胰腺癌细胞的增殖.
结论:
- SOCS7是一种多功能且强大的E3联酶,用于产生向蛋白质降解剂.
- 这一发现为开发基于TPD的治疗方法提供了有希望的新途径,特别是针对由突变KRAS驱动的癌症.
- 该研究强调了SOCS7在向蛋白质降解中克服抵抗机制的潜力.
更多相关视频
05:33High-Throughput Cellular Profiling of Targeted Protein Degradation Compounds Using HiBiT CRISPR Cell Lines
Published on: November 9, 2020
9.6K
09:37Combining Non-reducing SDS-PAGE Analysis and Chemical Crosslinking to Detect Multimeric Complexes Stabilized by Disulfide Linkages in Mammalian Cells in Culture
Published on: May 2, 2019
10.1K
相关概念视频
02:58Regulated Protein Degradation
7.2K
It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
7.2K
02:11Proteins: From Genes to Degradation
12.2K
Within a biological system, the DNA encodes the RNA, and the nucleotide sequence in the RNA further defines the amino acid sequence in the protein. This is referred to as “The Central Dogma of Molecular Biology” - a term coined by Francis Crick. Central dogma is a firm principle in biology that defines the flow of genetic information within any life form. The two fundamental steps in central dogma are - transcription and translation.
Transcription is the synthesis of RNA...
Transcription is the synthesis of RNA...
12.2K
01:13The Proteasome
830
Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
830
02:04Covalently Linked Protein Regulators
6.8K
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
These groups modify specific amino acids in a protein....
6.8K
01:26Protein Modifications in the RER
5.1K
Modification of secretory and transmembrane proteins entering the rough ER begins in the ER lumen. These modifications aid in protein folding and stabilize the acquired tertiary structure. Protein modifications in the rough ER co-occur at different stages of protein folding.
Broadly, these modifications can be categorized into four main categories — glycosylation, formation of disulfide bonds, assembly of protein subunits, and specific proteolytic cleavages like removal of signal...
Broadly, these modifications can be categorized into four main categories — glycosylation, formation of disulfide bonds, assembly of protein subunits, and specific proteolytic cleavages like removal of signal...
5.1K
00:49Ligand Binding and Linkage
4.8K
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
4.8K